...
首页> 外文期刊>Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy >Nationwide survey of the development of drug-resistance in the pediatric field: drug sensitivity of Haemophilus influenzae in Japan.
【24h】

Nationwide survey of the development of drug-resistance in the pediatric field: drug sensitivity of Haemophilus influenzae in Japan.

机译:儿科耐药性发展的全国性调查:日本流感嗜血杆菌的药物敏感性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We evaluated the beta-lactamase-producing ability and resistance to 20 antibacterial agents of 448 clinically isolated strains of Haemophilus influenzae accumulated from October 2000 to July 2001 (phase 1) and of 376 different strains accumulated from January to June 2004 (phase 2), from institutions that participated in a nationwide Drug-Resistant Pathogen Surveillance Group in Pediatric Infectious Disease. Between phase 1 and phase 2 the proportion of beta-lactamase-negative ampicillin (ABPC)-susceptible (BLNAS) strains declined from 62.9% to 34.3%; the proportions of beta-lactamase-positive ABPC-resistant (BLPAR) strains were 8.3% and 6.4% in phases 1 and 2, but the proportion of beta-lactamase-negative ABPC-resistant (BLNAR) strains increased from 28.8% in phase 1 to 59.3% in phase 2. Comparison of the MIC(90) values of the antibacterial agents for H. influenzae in phase 1 and phase 2 showed that cefcapene, cefpodoxime, ceftriaxone, panipenem, and clarithromycin kept the same level, while cefdinir, faropenem, and rokitamycin showed 2-fold to 8-fold decreases. With the exception of the above antibiotics, all of the other antibacterial agents tested showed 2-fold to 4-fold increases. The MIC(90) values of the beta-lactam drugs for BLNAR were 2-fold to 32-fold higher than the values for BLNAS. The proportion of BLNAR H. influenzae strains rose dramatically over the 3 years between phases 1 and 2. In relation to age, prior administration of antibacterial agents, and attendance at a day nursery as background factors, no significant differences between BLNAS and BLNAR were detected in phase 1. In the phase 2 survey, the proportion of BLNAR strains showed significant differences between children under 3 years and those aged 3 years or more, and there were also significant differences according to whether antibacterial agents, especially beta-lactams, had been administered previously. No significant difference was found in resistant bacteria according to whether or not a child had attended a day nursery.
机译:我们评估了2000年10月至2001年7月(阶段1)累积的448例临床分离的流感嗜血杆菌菌株和2004年1月至2004年6月(阶段2)累积的376种不同菌株的β-内酰胺酶生产能力以及对20种抗菌剂的耐药性,来自参与全国小儿传染病抗药性病原体监测小组的机构。在阶段1和阶段2之间,β-内酰胺酶阴性氨苄青霉素(ABPC)易感性(BLNAS)菌株的比例从62.9%下降至34.3%。在阶段1和2中,β-内酰胺酶阳性ABPC耐药菌株的比例分别为8.3%和6.4%,但是在阶段1中,β-内酰胺酶阴性ABPC耐药菌株(BLNAR)的比例从28.8%增加在阶段2中降至59.3%。比较阶段1和阶段2中的流感嗜血杆菌抗菌剂的MIC(90)值表明,头孢卡培南,头孢泊肟肟,头孢曲松酮,帕尼培南和克拉霉素保持相同水平,而头孢地尼,法罗培南,而洛他霉素显示减少2到8倍。除上述抗生素外,所有测试的其他抗菌剂均显示出2倍至4倍的增加。 β-内酰胺类药物对BLNAR的MIC(90)值比BLNAS的值高2到32倍。在第1阶段和第2阶段之间的3年中,BLNAR流感嗜血杆菌菌株的比例急剧上升。关于年龄,之前服用抗菌药物和作为背景因素的托儿所的情况,未发现BLNAS和BLNAR之间有显着差异在第二阶段的调查中,BLNAR菌株的比例在3岁以下的儿童与3岁以上的儿童之间显示出显着差异,并且根据是否使用了抗菌剂(尤其是β-内酰胺类)也存在显着差异。以前管理过。根据孩子是否上过托儿所,抗性细菌没有发现显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号